Coherus Oncology, Inc. (CHRS) NASDAQ
1.72
-0.0785(-4.36%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 170.92M |
| Enterprise Value | 122.38M |
| P/E Ratio | 1.29 |
| PEG Ratio | -0 |
| Price/Sales Ratio | 5 |
| Price/Book Ratio | 3.55 |
| Enterprise/Revenue | 3.85 |
| Enterprise/EBITDA | -0.95 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
Profitability
| Profit Margin | 3.98 |
| Operating Margin | -4.3 |
Management Effectiveness
| Return On Assets | 0.65 |
| Return On Equity | 7.89 |
Income Statement
| Revenue | 42.17M |
| Revenue/Share | 0.35 |
| Gross Profit | 28.36M |
| EBITDA | -170.2M |
| Net Income | -170.29M |
| Diluted EPS | -1.45 |
Balance Sheet
| Total Cash | 172.13M |
| Total Cash/Share | 1.43 |
| Total Debt | 40.34M |
| Total Debt/Equity | 0.66 |
| Current Ratio | 1.46 |
| Book Value Per Share | 0.51 |
Price History
| 52-Week Change | 62.16 |
| 52-Week High | 2.62 |
| 52-Week Low | 0.71 |
| Moving Average 50 Days | 1.74 |
| Moving Average 200 Days | 1.48 |
Statistics
| Average Volume | 1.79M |
| Shares Outstanding | 117.14M |
| % Held by Institutions | 44.06 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
